Genomics and 3-Dimensional Brachytherapy for Cervical Cancer: Significant Steps Forward

In this issue of Oncology Scan, the Gynecologic Cancer editors discuss publications of molecular analysis of primary cervical cancer as part of the Cancer Genome Atlas project and advancements in 3-dimensional (3D) brachytherapy (BT) for cervical cancer. The genomic study highlights a specific type of cervical cancer classified as keratin-low, which has lower survival with surgery, and further work needs to be done to determine whether this difference in outcome holds true for patients treated with definitive chemoradiation therapy.

http://ift.tt/2f8VGMO